{"id":24618,"date":"2022-09-19T20:17:22","date_gmt":"2022-09-20T00:17:22","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=24618"},"modified":"2025-11-05T16:44:02","modified_gmt":"2025-11-05T21:44:02","slug":"thomas-urban-marron-md-phd","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/thomas-urban-marron-md-phd","title":{"rendered":"Thomas Urban Marron, MD, PhD"},"content":{"rendered":"\n<p>Dr. Marron\u2019s clinical trial aims to investigate the effect of IL-4 blockage in combination with PD-1 inhibition in the neoadjuvant setting for patients with non-small cell lung cancer (NSCLC). Recently, Dr. Marron found that IL-4, a cytokine classically associated with allergic disease, is produced within lung tumor lesions, and controls the development and differentiation of myeloid cells in the bone marrow and lung lesions. These observations were made initially in resected, treatment-na\u00efve NSCLC from patients, and were recapitulated in murine models of lung cancer.&nbsp;<\/p>\n\n\n\n<p>Building on these findings, Dr. Marron, who has extensive experience in the neoadjuvant setting, aims to elucidate whether the combination of anti-PD-1 cemiplimab and anti-IL-4 dupilumab can reduce tumor recurrence after surgery in this patient population. Furthermore, this trial provides a unique opportunity to study the treatment effect on cancer samples obtained during tumor resection, allowing to conduct state-of-the-art translational analysis to measure the impact of IL-4 blockade on tumor infiltrating and circulating myeloid cells.&nbsp;<\/p>\n\n\n\n<p>In addition, Dr. Marron has an ongoing clinical trial testing this immunotherapy combo in advanced NSCLC patients that previously have progressed under standard anti-PD(L)1 therapy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<p><strong><strong><strong><strong><strong><strong><strong><strong>Reversing pro-tumorigenic type-2 immunity with combined pre-operative IL-4Ralpha and PD-1 blockade for non-small cell lung cancer<\/strong><\/strong> <\/strong><\/strong> <\/strong><\/strong><\/strong>\u00a0<\/strong><br>Icahn School of Medicine at Mount Sinai | Lung Cancer | 2023<\/p>\n\n\n\n<p><strong><strong><strong><strong><strong><strong><strong><strong>The effect of neoadjuvant chemotherapy and chemo-immunotherapy on the NSCLC tumor microenvironment<\/strong><\/strong> <\/strong><\/strong> <\/strong><\/strong><\/strong>\u00a0<\/strong><br>Icahn School of Medicine at Mount Sinai | Lung Cancer | 2019<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Marron\u2019s clinical trial aims to investigate the effect of IL-4 blockage in combination with PD-1 inhibition in the neoadjuvant setting for patients with non-small cell lung cancer (NSCLC). Recently, Dr. Marron [&hellip;]<\/p>\n","protected":false},"featured_media":36372,"template":"","tax_cancer_type":[356],"tax_grant_type":[725],"tax_award_year":[480],"tax_institutions":[540],"tax_location_states":[494],"class_list":["post-24618","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CRI Clinical Innovator","quote":"","scientist_last_name":"Marron","show_on_landing":true,"scientist_publish_until":"20260731"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Thomas Urban Marron, MD, PhD<\/title>\n<meta name=\"description\" content=\"Dr. Marron and his team have designed a &quot;window-of-opportunity&quot; trial in which lung cancer patients are treated with PD-1 immunotherapy, with or without chemotherapy, prior to surgery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thomas Urban Marron, MD, PhD\" \/>\n<meta property=\"og:description\" content=\"Dr. Marron and his team have designed a &quot;window-of-opportunity&quot; trial in which lung cancer patients are treated with PD-1 immunotherapy, with or without chemotherapy, prior to surgery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-05T21:44:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1333\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd\",\"name\":\"Thomas Urban Marron, MD, PhD\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg\",\"datePublished\":\"2022-09-20T00:17:22+00:00\",\"dateModified\":\"2025-11-05T21:44:02+00:00\",\"description\":\"Dr. Marron and his team have designed a \\\"window-of-opportunity\\\" trial in which lung cancer patients are treated with PD-1 immunotherapy, with or without chemotherapy, prior to surgery.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg\",\"width\":1333,\"height\":2000,\"caption\":\"Thomas Marron\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thomas Urban Marron, MD, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thomas Urban Marron, MD, PhD","description":"Dr. Marron and his team have designed a \"window-of-opportunity\" trial in which lung cancer patients are treated with PD-1 immunotherapy, with or without chemotherapy, prior to surgery.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd","og_locale":"es_ES","og_type":"article","og_title":"Thomas Urban Marron, MD, PhD","og_description":"Dr. Marron and his team have designed a \"window-of-opportunity\" trial in which lung cancer patients are treated with PD-1 immunotherapy, with or without chemotherapy, prior to surgery.","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd","og_site_name":"Cancer Research Institute","article_modified_time":"2025-11-05T21:44:02+00:00","og_image":[{"width":1333,"height":2000,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd","name":"Thomas Urban Marron, MD, PhD","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg","datePublished":"2022-09-20T00:17:22+00:00","dateModified":"2025-11-05T21:44:02+00:00","description":"Dr. Marron and his team have designed a \"window-of-opportunity\" trial in which lung cancer patients are treated with PD-1 immunotherapy, with or without chemotherapy, prior to surgery.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg","width":1333,"height":2000,"caption":"Thomas Marron"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/thomas-urban-marron-md-phd#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Thomas Urban Marron, MD, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/09\/Marron-Thomas.jpeg","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/24618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/36372"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=24618"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=24618"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=24618"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=24618"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=24618"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=24618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}